Cardiorenal syndrome: A literature review

Area of Science:

• Nephrology
• Cardiology
• Clinical Medicine

Background:

• Increasing incidence of cardiorenal syndrome presents a significant clinical challenge.
• Current management relies heavily on diuretics, but diuretic resistance is common.
• Pathophysiology and optimal treatment strategies for cardiorenal syndrome require further elucidation.

Purpose of the Study:

• To review the current understanding of cardiorenal syndrome pathophysiology.
• To explore strategies for overcoming diuretic resistance in cardiorenal syndrome.
• To evaluate novel therapeutic modalities for cardiorenal syndrome management.

Main Methods:

• Review of existing literature on cardiorenal syndrome.
• Analysis of clinical trial data on diuretic resistance.
• Evaluation of emerging treatments including nesiritide, vasopressin antagonists, adenosine antagonists, and ultrafiltration.

Main Results:

• Diuretic resistance is a frequent complication in cardiorenal syndrome.
• Several novel treatment modalities have demonstrated promising efficacy.
• These include nesiritide, arginine vasopressin receptor antagonists, adenosine receptor antagonists, and ultrafiltration.

Conclusions:

• Cardiorenal syndrome management is complex due to increasing incidence and poorly understood pathophysiology.
• Strategies to counteract diuretic resistance are crucial for effective treatment.
• Emerging therapies offer potential advancements in managing cardiorenal syndrome.